CPC C12N 15/113 (2013.01) [A61K 9/0019 (2013.01); A61K 31/7088 (2013.01); A61K 47/54 (2017.08); A61K 47/543 (2017.08); A61K 47/549 (2017.08); A61K 47/551 (2017.08); A61K 47/554 (2017.08); A61P 1/00 (2018.01); A61P 1/16 (2018.01); A61P 5/00 (2018.01); A61P 9/00 (2018.01); A61P 11/00 (2018.01); A61P 13/12 (2018.01); C07H 21/00 (2013.01); C07H 21/02 (2013.01); C07H 21/04 (2013.01); C12N 15/111 (2013.01); C12N 2310/14 (2013.01); C12N 2310/312 (2013.01); C12N 2310/315 (2013.01); C12N 2310/346 (2013.01); C12N 2310/351 (2013.01); C12N 2310/3515 (2013.01); C12N 2320/32 (2013.01)] | 18 Claims |
1. A compound of formula (I):
![]() wherein:
O is an oligonucleotide;
L is a linker selected from:
![]() Xc is a cholesterol, Lithocholic acid, Retinoic acid or α-tocopheryl succinate; and
Zc is a phosphodiester or phosphodiester derivative selected from
![]() wherein X is O, S or BH3.
|